Style | Citing Format |
---|---|
MLA | Elahi Vahed I, et al.. "Expanding Genetic and Clinical Aspects of Schwartz-Jampel Syndrome: A Report of Two Cases With Literature Review." Molecular Genetics and Metabolism Reports, vol. 40, no. , 2024, pp. -. |
APA | Elahi Vahed I, Tehrani Fateh S, Kamali M, Hashemigorji F, Esmaeilzadeh Z, Sadeghi H, Miryounesi M, Ghasemi MR (2024). Expanding Genetic and Clinical Aspects of Schwartz-Jampel Syndrome: A Report of Two Cases With Literature Review. Molecular Genetics and Metabolism Reports, 40(), -. |
Chicago | Elahi Vahed I, Tehrani Fateh S, Kamali M, Hashemigorji F, Esmaeilzadeh Z, Sadeghi H, Miryounesi M, Ghasemi MR. "Expanding Genetic and Clinical Aspects of Schwartz-Jampel Syndrome: A Report of Two Cases With Literature Review." Molecular Genetics and Metabolism Reports 40, no. (2024): -. |
Harvard | Elahi Vahed I et al. (2024) 'Expanding Genetic and Clinical Aspects of Schwartz-Jampel Syndrome: A Report of Two Cases With Literature Review', Molecular Genetics and Metabolism Reports, 40(), pp. -. |
Vancouver | Elahi Vahed I, Tehrani Fateh S, Kamali M, Hashemigorji F, Esmaeilzadeh Z, Sadeghi H, et al.. Expanding Genetic and Clinical Aspects of Schwartz-Jampel Syndrome: A Report of Two Cases With Literature Review. Molecular Genetics and Metabolism Reports. 2024;40():-. |
BibTex | @article{ author = {Elahi Vahed I and Tehrani Fateh S and Kamali M and Hashemigorji F and Esmaeilzadeh Z and Sadeghi H and Miryounesi M and Ghasemi MR}, title = {Expanding Genetic and Clinical Aspects of Schwartz-Jampel Syndrome: A Report of Two Cases With Literature Review}, journal = {Molecular Genetics and Metabolism Reports}, volume = {40}, number = {}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Elahi Vahed I AU - Tehrani Fateh S AU - Kamali M AU - Hashemigorji F AU - Esmaeilzadeh Z AU - Sadeghi H AU - Miryounesi M AU - Ghasemi MR TI - Expanding Genetic and Clinical Aspects of Schwartz-Jampel Syndrome: A Report of Two Cases With Literature Review JO - Molecular Genetics and Metabolism Reports VL - 40 IS - SP - EP - PY - 2024 ER - |